Farag Kameel D. bought AKTX
November 1, 2025 · Form 4 insider transaction
Farag Kameel D. bought 32,000 shares of Akari Therapeutics, Plc at $0.75 per share, a transaction worth $24.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,000
Price
$0.75
Total value
$24.0K
InsiderFarag Kameel D.
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateNovember 1, 2025
Filing dateNovember 4, 2025
Shares owned after32,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer; These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026.